直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
Virginia E. Lefever
Associate
More
vCard
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
+1 202 408 4484
virginia.lefever@finnegan.com virginia.lefever@finnegan.com

Virginia E. Lefever

Associate

  • +1 202 408 4484 +1 202 408 4484
  • virginia.lefever@finnegan.com virginia.lefever@finnegan.com
  • 901 New York Avenue, NW
  • Washington, DC 20001-4413
  • vCard

With a foundation in biological sciences, public health policy, and direct intellectual property (IP) experience, Virginia Lefever applies a multidisciplinary perspective to her practice, specifically to matters related to technologies within the life sciences sector.

Virginia focuses on patent litigation and prosecution matters. She supports litigation teams by preparing case briefs, summarizing deposition transcripts, and conducting research on patentability, licensing, and commercialization of medical technologies. 

 

While in law school, Virginia externed with the Honorable Judge Kathy Bissoon at the U.S. District Court for the Western District of Pennsylvania. She also worked as a research assistant and concentrated on collaboration agreements between pharmaceutical companies and independent innovators. In her last semester, Virginia externed with a world-renowned hospital’s innovation center, conducting patentability analyses and drafting amendments to technology transfer agreements. 

 

Prior to law school, Virginia worked in healthcare policy and program evaluation, contributing to federal recommendations that achieved measurable financial benefits.

 

Et Cetera

  • Editor-in-chief, Health Matrix: Journal of Law-Medicine, 35, 2024-2025.

  • Author, “Medical Necessity and Prior Authorization: The Unregulated Power of Insurers,” Note in Health Matrix: Journal of Law-Medicine, 35, 301, 2025.

  • Recipient, Outstanding achievement in the law-medicine curriculum, Richard A. and Brandon S. Collier Award, 2025.

  • Recipient, Gerber Law-Medicine Fellowship, 2022-2025.

Insights

Federal Circuit IP Blog

Google’s Attorneys’ Fees Affirmed Against EscapeX IP Google’s Attorneys’ Fees Affirmed Against EscapeX IP

January 14, 2026

Federal Circuit IP Blog

Federal Circuit Upholds PTAB Recusal, Remands to Consider Copying Evidence Federal Circuit Upholds PTAB Recusal, Remands to Consider Copying Evidence

November 24, 2025

News

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll 61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Admissions and Education

Admissions

  • District of Columbia
  • Ohio

Education

Case Western Reserve Law School
J.D., Law,

cum laude, 2025

University of Michigan
M.P.H., Health Management and Policy, 2020
University of Pittsburgh
B.S., Political Science,

cum laude, 2018

University of Pittsburgh
B.S., Biological Sciences,

cum laude, 2018

Virginia's Practices

Diligence, Licensing, and Opinions
Licensing, Pooling, and Other Transactions

Virginia's Industries

Life Sciences
Medical Device and Diagnostics
Pharmaceutical

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP